Literature DB >> 32194172

Transdermal siRNA delivery by pH-switchable micelles with targeting effect suppress skin melanoma progression.

Mao-Ze Wang1, Jie Niu1, Hui-Jian Ma1, Haseeb Anwar Dad1, Hai-Tao Shao1, Tie-Jun Yuan1, Li-Hua Peng2.   

Abstract

Melanoma is an aggressive disease with rapid progression and fast relapse, representing one of the formidable challenges in clinic. Current systemic therapies for melanoma exhibit limited anticancer potential due to the lack of specificity and limited efficacy. Herein, we design a cationic polymer (SCP-HA-PAE) by conjugating skin/cell penetrating peptide (SCP) and hyaluronic acid (HA) to the amphipathic polymer (poly β-amino esters, PAE), then fabricate the nanocarriers (SHP) composed by SCP-HA-PAE for delivering siRNA to skin melanoma by transdermal application. SHP not only manifests the excellent ability in penetrating through skin stratum corneum (SC), targeting melanoma and being sensitive to pH, but also expresses the advantages in compacting the vector/siRNAs nanocomplexes and stimulating their endosome escape inside cells, which ensure the enhanced siRNA delivery efficiency. SHP/siRNA induce the strong efficacy in retarding the progression and relapse of skin melanoma through the enhanced apoptosis effect both in vitro & in vivo. This study provides a proof-of-concept design of pH-switchable cationic micelles as transdermal gene delivery nanoplatforms with targeting effect for melanoma therapy, which may be adapted widely in the treatment of various superficial tumors and skin genetic diseases.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cationic micelles; Skin melanoma; Transdermal delivery; Tumor targeting; pH triggered release; siRNA

Mesh:

Substances:

Year:  2020        PMID: 32194172     DOI: 10.1016/j.jconrel.2020.03.023

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  7 in total

Review 1.  Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.

Authors:  Muhammad Abdur Rahim; Nasrullah Jan; Safiullah Khan; Hassan Shah; Asadullah Madni; Arshad Khan; Abdul Jabar; Shahzeb Khan; Abdelbary Elhissi; Zahid Hussain; Heather C Aziz; Muhammad Sohail; Mirazam Khan; Hnin Ei Thu
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

2.  Preparation, Characterization, and In Vitro Anticancer Activity Evaluation of Broccoli-Derived Extracellular Vesicle-Coated Astaxanthin Nanoparticles.

Authors:  Chunmei Li; Qi Song; Xialian Yin; Ruilong Song; Gang Chen
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

Review 3.  Nanocarriers for Skin Applications: Where Do We Stand?

Authors:  Neha Tiwari; Ernesto Rafael Osorio-Blanco; Ana Sonzogni; David Esporrín-Ubieto; Huiyi Wang; Marcelo Calderón
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-01       Impact factor: 16.823

Review 4.  Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment.

Authors:  Fei Qu; Rui Geng; Yijing Liu; Jintao Zhu
Journal:  Theranostics       Date:  2022-04-11       Impact factor: 11.600

Review 5.  Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.

Authors:  Haseeb Anwar Dad; Ting-Wei Gu; Ao-Qing Zhu; Lu-Qi Huang; Li-Hua Peng
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

Review 6.  Novel Pharmaceutical Strategies for Enhancing Skin Penetration of Biomacromolecules.

Authors:  Luyu Zhang; Zirong Dong; Wenjuan Liu; Xiying Wu; Haisheng He; Yi Lu; Wei Wu; Jianping Qi
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-16

7.  Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL-programmed therapy against melanoma.

Authors:  Li-Hua Peng; Mao-Ze Wang; Yang Chu; Lei Zhang; Jie Niu; Hai-Tao Shao; Tie-Jun Yuan; Zhi-Hong Jiang; Jian-Qing Gao; Xing-Hai Ning
Journal:  Sci Adv       Date:  2020-07-03       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.